GB Sciences (GBLX) Stock Price, News & Analysis

Company Overview

GB Sciences, Inc., a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

Key Stats

• Today's Range: $0.0040 to $0.0050
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0135
• Volume: 15,603 shs
• Average Volume: 185,025 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GBLX Stock Analysis - Frequently Asked Questions

How have GBLX shares performed this year?

GB Sciences' stock was trading at $0.0040 at the start of the year. Since then, GBLX shares have increased by 25.0% and is now trading at $0.0050.
View the best growth stocks for 2025 here.

How were GB Sciences' earnings last quarter?

GB Sciences, Inc. (OTCMKTS:GBLX) issued its earnings results on Monday, November, 14th. The company reported ($0.04) earnings per share (EPS) for the quarter.

How do I buy shares of GB Sciences?

Shares of GBLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of GB Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that GB Sciences investors own include Canopy Growth (CGC), 22nd Century Group (XXII), NVIDIA (NVDA), Unrivaled Brands (TRTC), Trees (CANN), Aurora Cannabis (ACB) and Meta Platforms (META).

Company Calendar

• Last Earnings: 11/14/2016
• Today: 1/21/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:GBLX
• CUSIP: N/A
• CIK: 1165320
• Web: gbsciences.com
• Phone: (866) 721-0297
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A